Skip to main content

A disruptive Magnetically Enhanced Library preparation platform for Next Generation Sequencing

Project description

New lab device will democratise next-generation sequencing

Next generation sequencing (NGS) is a powerful new tool for biological and clinical research, but it remains inaccessible and unaffordable to smaller laboratories, clinics and companies due to low-reproducibility manual library preparations, expensive reagents, and scarce biological samples. MAGELIA is a new automated and miniaturised sample preparation platform for NGS at small scales. It requires sample volumes 100-1 000 times smaller than traditional NGS volumes in a completely automated platform for better reproducibility. MAGELIA aims to democratise NGS; in this phase, the project will accelerate time-to-market, increase funding for commercialisation, and reach out to a broad potential customer base.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Coordinator

INOREVIA
Net EU contribution
€ 1 955 100,00
Address
29 Rue Du Faubourg Saint-jacques
75014 Paris
France

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 837 900,00